Novo A/S

Average Profitability
10.62%
Insider Buys Quantity
22
Insider Buys Sum
$186.68M
Insider Sells Quantity
35
Insider Sells Sum
$321.65M

Insider Activity of Novo A/S

According to the SEC Form 4 filings, Novo A/S, being in a position of

  1. 10 percent owner at IO Biotech, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1392618 shares for $1.89M,
    over all time since 2021-11-09, has bought 2794135 shares for $9.55M, and sold 1392618 shares for $1.89M.

The largest purchase of all time was on 2022-02-08 and amounted to 1666666 shares of Arcellx, Inc. for $25M.

The largest sale of all time was on 2014-11-04 and amounted to 4000000 shares of Inogen, Inc. for $86M.

Biography of Novo A/S

No biography is available at this moment.

2024-07-26SaleIO Biotech, Inc.
IOBT
10 percent owner
23,478
0.0362%
$1.31$30,787-7.75%
2024-07-25SaleIO Biotech, Inc.
IOBT
10 percent owner
51,522
0.0774%
$1.33$68,339-11.19%
2024-05-10SaleIO Biotech, Inc.
IOBT
10 percent owner
658,809
0.8518%
$1.22$802,495-17.33%
2024-03-21SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
465,021
1.1289%
$0.75$350,951-25.2%
2024-03-20SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
359,979
0.8709%
$0.73$264,081-24.19%
2024-03-19SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
593,000
1.4693%
$0.76$447,715-22.88%
2024-03-18SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
842,020
2.0939%
$0.77$647,008-22.28%
2024-03-14SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
1.91M
0.8272%
$0.89$1.7M-29.59%
2024-02-09SaleIO Biotech, Inc.
IOBT
10 percent owner
658,809
0.8023%
$1.50$988,411-13.19%
2023-08-09PurchaseIO Biotech, Inc.
IOBT
10 percent owner
2.47M
9.534%
$2.02$5M-18.06%
2023-02-16PurchaseSpruce Biosciences, Inc.
SPRB
10 percent owner
2.21M
0.0087%
$3.17$7M-11.16%
2022-09-14PurchaseEdgewise Therapeutics, Inc.
EWTX
10 percent owner
484,496
0.9211%
$10.32$5M-14.66%
2022-02-08PurchaseArcellx, Inc.
ACLX
10 percent owner
1.67M
6.7728%
$15.00$25M+6.58%
2021-11-09PurchaseIO Biotech, Inc.
IOBT
10 percent owner
325,000
7.8787%
$14.00$4.55M-62.27%
2021-06-21PurchaseVerve Therapeutics, Inc.
VERV
10 percent owner
700,000
4.5226%
$19.00$13.3M-7.41%
2021-06-02SaleInogen, Inc.
INGN
10 percent owner
680,000
2.9808%
$57.32$38.98M-41.64%
2021-05-19SaleSpruce Biosciences, Inc.
SPRB
10 percent owner
475,000
1.8365%
$13.90$6.6M-71.54%
2021-03-30PurchaseEdgewise Therapeutics, Inc.
EWTX
10 percent owner
1.25M
1.3005%
$16.00$20M-42.5%
2021-03-01SaleInogen, Inc.
INGN
10 percent owner
790,000
3.2841%
$49.00$38.71M-7.32%
2021-01-28SaleInozyme Pharma, Inc.
INZY
10 percent owner
375,000
1.469%
$21.00$7.88M-30.07%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.